Drug repositioning nominated the vasodilator vincamine, which downregulated Lrp10, Lamc1 in cortex tissue, and effectively inhibited the tau protein propagation from the medial entorhinal cortex (MEC) to the hippocampus in female AD mice. Here, LAMC1 is linked to Alzheimer disease.